Cabaletta Bio, Inc. (CABA)
NASDAQ: CABA · Real-Time Price · USD
2.900
+0.010 (0.35%)
At close: Oct 15, 2025, 4:00 PM EDT
2.890
-0.010 (-0.34%)
After-hours: Oct 15, 2025, 7:55 PM EDT
Cabaletta Bio Market Cap
Cabaletta Bio has a market cap or net worth of $265.25 million as of October 15, 2025. Its market cap has increased by 27.47% in one year.
Market Cap
265.25M
Enterprise Value
95.46M
1-Year Change
27.47%
Ranking
Category
Stock Price
$2.90
Market Cap Chart
Since October 25, 2019, Cabaletta Bio's market cap has increased from $235.53M to $265.25M, an increase of 12.62%. That is a compound annual growth rate of 2.01%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 14, 2025 | 264.33M | 138.24% |
Dec 31, 2024 | 110.95M | -88.59% |
Dec 29, 2023 | 972.68M | 260.85% |
Dec 30, 2022 | 269.55M | 151.03% |
Dec 31, 2021 | 107.38M | -64.23% |
Dec 31, 2020 | 300.21M | -10.59% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Oct 25, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 748.25B |
Johnson & Johnson | 459.32B |
AbbVie | 407.19B |
UnitedHealth Group | 321.06B |
AstraZeneca | 264.75B |
Novo Nordisk | 260.80B |
Novartis AG | 253.85B |
Abbott Laboratories | 230.73B |